Human Growth Hormone Market Size, Share, By Product [Long Acting, and Others (Short Acting, and Intermediate Acting)], By Route of Administration (Subcutaneous, Intramuscular, and Intravenous), By Application (Growth Hormone Deficiency (GHD), Adult GH Def

Human Growth Hormone Market Size, Share, By Product [Long Acting, and Others (Short Acting, and Intermediate Acting)], By Route of Administration (Subcutaneous, Intramuscular, and Intravenous), By Application (Growth Hormone Deficiency (GHD), Adult GH Deficiency, Pediatric GH Deficiency, Turner Syndrome, Idiopathic Short Stature, Prader-Willi Syndrome, Small For Gestational Age, and Others), By Distribution Channel and By Region - Trends, Analysis and Forecast till 2034

Human growth hormone market is driven by growing awareness of growth hormones and increased utilization for the treatment of hormonal imbalance disorders. In addition, the increasing incidence of growth hormone deficiencies and high R&D investment and methodologies for transforming treatment practices are other factors propelling the growth of the global market. Furthermore, technological advancements which increase the efficiency and cost-effectiveness of production is also anticipated to create opportunities for growth of the global market over the forecast period.

Human Growth Hormone Market Report Highlights:

• The human growth hormone market size was valued at USD 6.33 billion in 2023.
• The market is expected to be USD 18.3 billion by 2034 growing at a CAGR of 6.33%.
• North America held the largest share of the market in 2024.
• The long-acting segment is expected to dominate the market by product.
• Europe is projected to be the fastest-growing market in the coming years.
• By route of administration, the subcutaneous segment holds the largest share of the market.
• By application, the growth hormone deficiency segment holds the largest share of the market.
• By distribution channel, the hospital pharmacy is expected to dominate the target market growth.

Human Growth Hormone Market Key Highlights:

North America: This region is expected to dominate the growth of the market during forecast period due to the growing healthcare awareness among people, significant government initiatives, increasing R&D activities, presence of organizations, and others.

Europe: This region is considered to be the fastest-growing region in the target market due to the increasing burden of growth hormone deficiencies, the availability of artificial growth hormones, extensive research and development activities, and others.

Human Growth Hormone Market Report Analysis:

Normal Physiology of Growth Hormone in Adults:

The release of growth hormone (GH) is also influenced by age, pubertal status, and gender. Younger persons have a much higher integrated 24-hour GH concentration than older ones, and women have a significantly higher concentration than men. Age and gender had no effect on GH concentration after adjusting for the effects of oestradiol, and the serum concentration of free oestradiol correlates with GH but not free testosterone. This implies that regulating GH secretion is a critical function of oestrogens. Pulsatile GH secretion increases threefold during puberty and peaks around the age of 15 for girls and a year later for boys.

Browse ∼52 market data tables and ∼46 figures through ∼189 slides and in-depth TOC on “Human Growth Hormone Market Size, Share, By Product [Long Acting and Others (Short Acting, and Intermediate Acting)], By Route of Administration (Subcutaneous, Intramuscular, and Intravenous), By Application (Growth Hormone Deficiency (GHD), Adult GH Deficiency, Pediatric GH Deficiency, Turner Syndrome, Idiopathic Short Stature, Prader-Willi Syndrome, Small For Gestational Age, and Others), By Distribution Channel and By Region - Trends, Analysis and Forecast till 2034”

Competitive Landscape of Human Growth Hormone Market:

The key players operating in the human growth hormone market Include Novo Nordisk, ELI LILLY CANADA INC., Pfizer Inc., Genetech, Inc., Merck KGaA, Ferring, Teva Pharmaceutical Industries Ltd., Aliyun.com, Changchun GeneScience Pharmaceutical Co., Ltd., Ascendis Pharma, PatSnap, F. Hoffmann-La Roche Ltd., and Sandoz AG.